Senior Lecturer in Medicine, NUI Galway
Diabetetic foot ulcers, burns and epidermolysis bullosa including the application of stem cell biology, gene therapy and biomaterials science to wound healing.
Researcher in
2005 - Present Senior Lecturer in Medicine, NUIG & Consultant Endocrinologist, Galway University Hospital
2004 "Over and Above” Award, Addenbrooke's Hospital Foot Team & Southern Cambridgeshire Community Diabetes, Team, UK
2002/2003 Outstanding Achievement Award, DAFNE Programme, Addenbrooke's Hospital, Cambridge, UK
O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T. Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Low Extrem Wounds. 2010 Jun;9(2):90-102. Review.
Dinneen, S F., O' Hara, M C., Byrne, M., Newell, J., Daly, L., O' Shea, D., Smith, D., and Irish DAFNE Study Group. The Irish DAFNE Study Protocol: A cluster randomised trial of group versus individual follow-up after structured education for Type 1 diabetes. Trials 2009, 10:88
Glynn, L G., Buckley, B., Reddan, D., Newell, J., Hinde, J., Dinneen, S F., Murphy, A W. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. British Journal of General Practice. 58(552):488-94, 2008 Jul.
Hartweg J, Perera R, Montori V, Dinneen S, Neil HAW, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.:CD003205. DOI: 10.1002/14651858.CD003205.pub2.
Palmer AJ, Dinneen S, Gavin JR III, Gray A, Herman WH, Karter AJ. Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes. Curr Med Res Opin 2006;22:861-72.
Sarker A, Semple RK, Dinneen SF, O’Rahilly S, Martin SC. Severe hypoalphalipoproteinemia during treatment with rosiglitazone. Diabetes Care 2004;27:2577-80.
Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ. Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy. Diabet Med 2003;20:277-282.
Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS. Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 2002; 15:136-42
Gerstein HC, Mann JFE, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426
Principal Investigator on “The West of Ireland Diabetes Foot Study: Epidemiology, cost, feasibility and implications for clinical practice and policy”. Funded by the Diabetes Federation of Ireland and Medical Research Charities Group in conjunction with the Health Research Board; €217,571 over 3 years.
Co-Investigator on “Patient Monitoring and Feedback Mechanism for Neuropathic Feet”. PI is Dr Martin Glavin, Department of Electronic Engineering, NUI, Galway. Funded by Enterprise Ireland Commercialisation Fund Proof of Concept Phase 2007
Co-Investigator for “Towards a national diabetes register for Ireland: theory, practice and policy”, PI is Prof Colin Bradley, Department of General Practice, UCC. Funded by the Health Research Board’s Health Services R&D Awards 2006. Total award €932,480; NUI, Galway allocation €96,483 over 4 years.
Co-Investigator for “Towards a national diabetes register for Ireland: theory, practice and policy”, PI is Prof Colin Bradley, Department of General Practice, UCC. Funded by the Health Research Board’s Health Services R&D Awards 2006. Total award €932,480; NUI, Galway allocation €96,483 over 4 years.
Principal Investigator on “Implementing and evaluating a structured education programme and a new model of ongoing care for Type 1 diabetes: the Irish DAFNE Study”. Funded in March 2005 by the Health Research Board’s Health Services R&D Awards; 1.2 million Euro over 5 years
